Eneomey

Eneomey is a French dermocosmetic skincare brand based in Cagnes-sur-Mer, on the Côte d'Azur, and founded by Audrey Talayrach. Its products are built around peeling technology and precisely dosed active ingredients, with glycolic acid at the centre, and are sold mainly through dermatologists, aesthetic doctors and pharmacies. The brand identifies itself by the line "Results my skin loves."

The company places its origins on more than one date, distinguishing the underlying expertise from the brand itself. Talayrach's range of peels and dermo-cosmetic products was first created in 1986, in collaboration with international physicians; the ENEOMEY brand as a distinct entity dates to 2015, when the company also set up a French research and development centre and began manufacturing in France [2]. A consumer launch followed in 2017. By the company's account, Eneomey is distributed in 18 countries and remains in active development [10].

Eneomey was founded by Audrey Talayrach, who is described as having worked with international dermatologists, surgeons and aesthetic physicians for some 30 years before establishing the laboratory [2]. According to the company, that long collaboration shaped a range of "active dermo-cosmetic products inspired by peeling technology," developed by a team based in the South of France.

Talayrach has framed the brand around a single founding idea: that effective skincare need not be unpleasant to use. In a brand interview she recalled an industry assumption that "a skincare product that didn't smell good was a skincare product that worked," and set out instead to combine high concentrations of active ingredients with agreeable textures and scents. The same interview describes entrepreneurial work beginning in 1999 and credits a deliberate emphasis on creative freedom in the company's early years.

The dating of the company is layered, and the brand's own history page records the layers explicitly. It lists 1986 as the creation of the original peel and dermo-cosmetic range, 1999 as that range's launch in France, and 2015 as the creation of the ENEOMEY brand itself [2]. Glowpedia treats 2015 as the founding year of the brand entity, with 1986 recorded as the earlier origin of the underlying product range rather than a competing date. (A search-engine summary elsewhere referenced a 2008 creation date for "Laboratoire Eneomey," but that figure does not appear on any verified brand or editorial page and is not used here.)

The brand's published timeline runs from a professional-peeling background to a consumer skincare line. After the 1986 range and its 1999 French launch, the ENEOMEY brand, R&D centre and French manufacturing were established in 2015 [2]. The consumer brand launched in 2017 alongside its DAYLIGHT C20 antioxidant day cream, which the company markets as its flagship anti-ageing product.

In 2018 the company introduced SUNLIGHT SCREEN 50+, presented as a sun protection guarding against UVA, UVB, infrared and blue light, together with a densifying programme aimed at what it calls "inflamm'aging." In 2022 its range of peels was reclassified as Class IIa medical devices [2]. More recently, an Australian distributor reported a market launch in April 2025, with events in Brisbane, Sydney and Melbourne [10].

Eneomey positions itself as a dermocosmetic brand sitting between mass-market and luxury skincare, sold through medical and pharmacy channels rather than general retail. Its stated approach pairs clinical effectiveness with sensory appeal: the company describes formulas built on a "precise dosage of key ingredients" and an intentionally "subtle and fleeting" signature fragrance, and says it distils 30 years of knowledge into simplified routines of three to four products.

The name is presented as an acronym — E for energy, NEO for renewal and MEY for the individual ("me") — and the company frames its mission as working "inside women's skin." Eneomey describes itself as "a brand designed by women, for women," a positioning echoed by an Australian distributor that called it "built by women, for women" [10]. The brand's French identity is part of its pitch, which it characterises as a "non-intrusive" approach to beauty.

Eneomey's catalogue centres on facial skincare — cleansers, day and night care, sun protection, masks, eye and lip care, and body products — alongside professional peels. The range is organised into themed "dermocosmetic programs" for concerns such as smoothing, firming, densifying, depigmenting and purifying, intended to be selected with a dermatologist, aesthetic doctor or pharmacist.

Glycolic acid is the brand's defining ingredient. Eneomey describes itself as a pioneer in integrating the glycolic acid molecule into dermo-cosmetic products and says it formulates with up to 30 percent glycolic acid "while respecting regulations and consumer safety" [6]. The same family of products is offered at graded strengths — the brand cites 8, 15 and 30 percent — reflecting its emphasis on precision dosing. Its formulation work has since extended to other actives including hyaluronic acid, vitamin C and phytic acid, and several proprietary complexes are marketed under names such as Bioregul, BIox and Time Cell.

Named products include DAYLIGHT C20, the antioxidant day cream launched in 2017; SUNLIGHT SCREEN 50+, the multi-radiation sunscreen; and night and anti-ageing creams such as STIM RENEW 15 and the refillable REJUV SILK. The company states that its formulas are developed by a multidisciplinary team spanning skin biology, chemistry, pharmacology and formulation, that products undergo clinical tolerance testing under dermatological supervision before release, and that independent laboratories validate their efficacy [5].

Outside its own channels, Eneomey has been profiled by sector publications rather than mainstream press. A Female Founder spotlight by the Australian distributor Dermocosmètica covered Talayrach and the brand's 2025 Australian launch, noting distribution in 18 countries [10]. The UK skincare retailer Dermoi describes Eneomey as a French dermocosmetic brand and a pioneer in glycolic-acid skincare with clinical tolerance testing [11]. No English-language Wikipedia article exists for the brand.

Eneomey is an active brand. It operates a live e-commerce site, maintains an ongoing product range — including refills and a peel line upgraded to Class IIa medical devices in 2022 — and publishes a regular blog under the name "By Your Side." The most recent activity recorded in available sources is its Australian market launch in April 2025 [10].